Sugikawa E, Yazaki N, Tsunoda S, Nakanishi N, Ohashi M
Drug Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., 2-2-50 Kawagishi, Saitama, Toda, 335-8505, Japan.
Biochem Biophys Res Commun. 1999 Aug 2;261(2):256-63. doi: 10.1006/bbrc.1999.1019.
The tumor suppressor protein p53 is a phosphoprotein and has growth and transformation suppression functions. Phosphorylation of wild-type p53 is known to modulate its function. To investigate the role of phosphorylation in modulating the functions of mutant p53, we constructed a series of phosphorylation site mutants based on mutant p53 Ala143 (p53-143) and p53 His175 (p53-175). When transfected into p53-negative Saos-2 cells, parental mutant p53-143 and p53-175 abolished both growth suppression and induction of apoptosis. However, DNA-activated protein kinase (DNA-PK) or cyclin-dependent kinase (cdks) phosphorylation site double mutants partially restored the growth suppression and induction of apoptosis and recovered the p53-specific DNA binding activity. We also observed a difference in sensitivity to calpain from parental mutants p53-175 and p53-175/15 or p53-175/315. These results suggest that the lack of phosphorylation at either the DNA-PK or cdks site in p53 mutants partially restores the wild-type functions by altering their conformation.
肿瘤抑制蛋白p53是一种磷蛋白,具有生长抑制和转化抑制功能。已知野生型p53的磷酸化可调节其功能。为了研究磷酸化在调节突变型p53功能中的作用,我们基于突变型p53 Ala143(p53-143)和p53 His175(p53-175)构建了一系列磷酸化位点突变体。当转染到p53阴性的Saos-2细胞中时,亲本突变型p53-143和p53-175消除了生长抑制和凋亡诱导。然而,DNA激活蛋白激酶(DNA-PK)或细胞周期蛋白依赖性激酶(cdks)磷酸化位点双突变体部分恢复了生长抑制和凋亡诱导,并恢复了p53特异性DNA结合活性。我们还观察到亲本突变型p53-175与p53-175/15或p53-175/315对钙蛋白酶的敏感性存在差异。这些结果表明,p53突变体中DNA-PK或cdks位点缺乏磷酸化通过改变其构象部分恢复了野生型功能。